In the last few months, I’ve been trying to keep you up-to-date in the field of personalized genetics. But recently, it has become really hard to follow all the news and announcements about this unique field of medicine. That’s why I had to divide my new report into several parts and share these links with you during the upcoming weekend. Enjoy the first part!
- Personalized genomes go mainstream (Nature): Details about Navigenics and 23andMe, which are companies focusing on personalized genetics.
- Should we all be testing our DNA? (BBC): A comprehensive report from Lissa Cook.
- Personalized Medicine leaves public confused (Genetics and Health): Members of the public seem to be afraid of possible impacts on their families and relatives, as personalization might lead to stigmatisation.
- Moving Forward with Personalized Medicine (Mind to Market):
There are also regulatory hurdles to overcome. Very few FDA guidelines for clinical trials of Personalized Medicine therapies exist. PM is also going to require some very highly integrated information systems, combining the whole of the biomedical knowledge base with the patient’s own electronic record.
- Giving personalized medicine a bad name (Health Business Blog):
In my view it would be best to limit the term personalized medicine to companion diagnostics, a worthwhile application that’s not especially controversial. Call the other stuff genetic testing or screening.
- How personal will Personalized Medicine become?: This is a must-read from a new blog written by Tim Grammer:
Ok, so now I have your DNA. I run the test on you and find that you have a DNA sequence that has been shown to be linked to heart disease. What do you do? Well, it is important that you understand probability and the fact that this DNA sequence does not guarantee that you will have heart disease. You should find out how strong the statistical correlation is between the DNA marker and the likelihood you’ll get heart disease. The correlation may be strong, hence you are likely to suffer the illness, or could be weak, in case you are at less risk.